SEC Form 4 · accession 0001179110-15-004956
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan M Peacock
Officer — President and CEO · Director
Period of report
Mar 12, 2015
Accepted (ET)
Mar 16, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.22 | Mar 12, 2015 | A | 16,000 | A | — | Mar 11, 2025 | Common Stock | 16,000 | 16,000 | D |
| Stock Option (right to buy)F2 | $10.22 | Mar 12, 2015 | A | 60,000 | A | — | Mar 11, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1This option vested as to 25% of the underlying shares on March 13, 2015 (the "Vesting Commencement Date") and vests as to an additional 25% of the underlying shares on each of the first, second and third anniversaries of the Vesting Commencement Date.
- F2This option was granted on March 12, 2015. This option vests as to 25% of the underlying shares on each one year anniversary of the date of grant.